Scott B. Ullem
Net Worth

Last updated:

What is Scott B. Ullem net worth?

The estimated net worth of Mr. Scott B. Ullem is at least $59,884,477 as of 9 Dec 2024. He owns shares worth $2,452,215 as insider, has earned $48,952,262 from insider trading and has received compensation worth at least $8,480,000 in Edwards Lifesciences Corporation.

What is the salary of Scott B. Ullem?

Mr. Scott B. Ullem salary is $1,060,000 per year as Corporation Vice President & Chief Financial Officer in Edwards Lifesciences Corporation.

How old is Scott B. Ullem?

Mr. Scott B. Ullem is 58 years old, born in 1967.

What stocks does Scott B. Ullem currently own?

As insider, Mr. Scott B. Ullem owns shares in one company:

Company Title Shares Price per share Total value
Edwards Lifesciences Corporation (EW) Corporation Vice President & Chief Financial Officer 30,561 $80.24 $2,452,215

What does Edwards Lifesciences Corporation do?

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

EW logo
EW
Edwards Lifesciences Corporation
$80.24

Scott B. Ullem insider trading

Edwards Lifesciences Corporation

Mr. Scott B. Ullem has made 33 insider trades between 2017-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 80,700 units of EW stock on 10 May 2023. As of 9 Dec 2024 he still owns at least 30,561 units of EW stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (Right to Acquire) 11,250 $45.28 $509,366
Option
Common Stock 11,250 $45.28 $509,366
Sale
Common Stock 11,250 $71.68 $806,411
Option
Employee Stock Option (Right to Acquire) 5,625 $45.28 $254,683
Sale
Common Stock 5,225 $87.47 $457,015
Sale
Common Stock 400 $88.11 $35,245
Option
Common Stock 5,625 $45.28 $254,683
Option
Common Stock 5,625 $45.28 $254,683
Option
Employee Stock Option (Right to Acquire) 5,625 $45.28 $254,683
Sale
Common Stock 5,625 $90.45 $508,804
Option
Employee Stock Option (Right to Acquire) 14,510 $36.75 $533,243
Sale
Common Stock 14,510 $76.55 $1,110,799
Option
Common Stock 14,510 $36.75 $533,243
Option
Common Stock 7,255 $36.75 $266,621
Option
Employee Stock Option (Right to Acquire) 7,255 $36.75 $266,621
Sale
Common Stock 7,255 $62.66 $454,569
Sale
Common Stock 7,255 $69.54 $504,527
Option
Employee Stock Option (Right to Acquire) 7,255 $36.75 $266,621
Option
Common Stock 7,255 $36.75 $266,621
Option
Common Stock 7,255 $36.75 $266,621
Option
Employee Stock Option (Right to Acquire) 7,255 $36.75 $266,621
Sale
Common Stock 7,255 $77.79 $564,366
Sale
Common Stock 7,255 $84.35 $611,959
Option
Common Stock 7,255 $36.75 $266,621
Option
Employee Stock Option (Right to Acquire) 7,255 $36.75 $266,621
Option
Common Stock 7,255 $36.75 $266,621
Sale
Common Stock 7,255 $93.27 $676,674
Option
Employee Stock Option (Right to Acquire) 7,255 $36.75 $266,621
Option
Common Stock 80,700 $35.2 $2,840,398
Sale
Common Stock 64,119 $88.36 $5,665,619
Sale
Common Stock 16,581 $89.22 $1,479,390
Option
Employee Stock Option (Right to Acquire) 80,700 $35.2 $2,840,398
Option
Common Stock 14,831 N/A N/A
Option
Performance Rights 14,831 N/A N/A
Option
Performance Rights 17,193 N/A N/A
Option
Common Stock 17,193 N/A N/A
Option
Employee Stock Option (Right to Acquire) 33,150 $21.76 $721,344
Sale
Common Stock 33,150 $78.73 $2,609,866
Option
Common Stock 33,150 $21.76 $721,344
Option
Employee Stock Option (Right to Acquire) 33,150 $21.76 $721,344
Option
Common Stock 33,150 $21.76 $721,344
Sale
Common Stock 33,150 $84.03 $2,785,595
Option
Common Stock 33,150 $21.76 $721,344
Sale
Common Stock 33,150 $21.76 $721,344
Option
Employee Stock Option (Right to Acquire) 33,150 $21.76 $721,344
Sale
Common Stock 33,150 $21.76 $721,344
Option
Common Stock 33,150 $21.76 $721,344
Option
Employee Stock Option (Right to Acquire) 33,150 $21.76 $721,344
Option
Common Stock 26,700 $13.98 $373,266
Option
Employee Stock Option (Right to Acquire) 26,700 $13.98 $373,266
Sale
Common Stock 26,700 $13.98 $373,266
Sale
Common Stock 26,700 $13.98 $373,266
Option
Common Stock 26,700 $13.98 $373,266
Option
Employee Stock Option (Right to Acquire) 26,700 $13.98 $373,266
Sale
Common Stock 26,700 $13.98 $373,266
Option
Employee Stock Option (Right to Acquire) 26,700 $13.98 $373,266
Option
Common Stock 26,700 $13.98 $373,266
Option
Employee Stock Option (Right to Acquire) 26,700 $13.98 $373,266
Sale
Common Stock 26,700 $69.82 $1,864,167
Option
Common Stock 26,700 $13.98 $373,266
Option
Common Stock 6,606 N/A N/A
Option
Performance Rights 6,606 N/A N/A
Option
Employee Stock Option (Right to Acquire) 7,500 $41.94 $314,550
Sale
Common Stock 7,500 $41.94 $314,550
Option
Common Stock 7,500 $41.94 $314,550
Option
Common Stock 7,500 $41.94 $314,550
Option
Employee Stock Option (Right to Acquire) 7,500 $41.94 $314,550
Sale
Common Stock 7,500 $41.94 $314,550
Option
Common Stock 7,500 $41.94 $314,550
Option
Employee Stock Option (Right to Acquire) 7,500 $41.94 $314,550
Sale
Common Stock 7,500 $41.94 $314,550
Sale
Common Stock 7,500 $41.94 $314,550
Option
Employee Stock Option (Right to Acquire) 7,500 $41.94 $314,550
Option
Common Stock 7,500 $41.94 $314,550
Option
Common Stock 7,500 $41.94 $314,550
Sale
Common Stock 7,500 $41.94 $314,550
Option
Employee Stock Option (Right to Acquire) 7,500 $41.94 $314,550
Option
Common Stock 7,500 $41.94 $314,550
Option
Employee Stock Option (Right to Acquire) 7,500 $41.94 $314,550
Sale
Common Stock 7,500 $41.94 $314,550
Option
Performance Rights 2,784 N/A N/A
Option
Common Stock 2,784 N/A N/A
Sale
Common Stock 25,036 $140.8 $3,524,944
Option
Employee Stock Option (Right to Acquire) 25,036 $34.05 $852,476
Option
Common Stock 25,036 $34.05 $852,476
Option
Common Stock 25,000 $34.05 $851,250
Sale
Common Stock 25,000 $136.55 $3,413,725
Option
Employee Stock Option (Right to Acquire) 25,000 $34.05 $851,250
Sale
Common Stock 25,000 $145.97 $3,649,325
Option
Common Stock 25,000 $34.05 $851,250
Option
Employee Stock Option (Right to Acquire) 25,000 $34.05 $851,250
Option
Employee Stock Option (Right to Acquire) 25,000 $34.05 $851,250
Option
Common Stock 25,000 $34.05 $851,250
Sale
Common Stock 25,000 $141.2 $3,530,100
Option
Performance Rights 9,712 N/A N/A
Option
Common Stock 9,712 N/A N/A
Sale
Common Stock 25,000 $134.87 $3,371,675
Option
Common Stock 25,000 $34.05 $851,250
Option
Employee Stock Option (Right to Acquire) 25,000 $34.05 $851,250
Option
Employee Stock Option (Right to Acquire) 25,000 $34.05 $851,250
Option
Common Stock 25,000 $34.05 $851,250
Sale
Common Stock 25,000 $137.26 $3,431,575
Option
Employee Stock Option (Right to Acquire) 25,000 $34.05 $851,250
Sale
Common Stock 25,000 $137.85 $3,446,125
Option
Common Stock 25,000 $34.05 $851,250
Option
Common Stock 10,500 N/A N/A
Option
Performance Rights 10,500 N/A N/A

Edwards Lifesciences key executives

Edwards Lifesciences Corporation executives and other stock owners filed with the SEC: